Literature DB >> 33392057

Laboratory organisation and management of SARS-CoV-2 infection in Niger, West Africa.

Abdourahamane Yacouba1,2, Adamou Lagaré2,3, Daouada Alhousseini Maiga1,2, Halimatou Moumouni Sambo2,4, Sani Ousmane2,3, Zelika Hamidou Harouna2,5, Boubacar Marou1, Maman K Sanoussi2, Balki Aoula2, Ali Amadou2,6, Hassane Boureima2,7, Saidou Amatagas2,8, Abdoulaye Ousmane9, Eric Adehossi1,10, Saidou Mamadou1,10.   

Abstract

BACKGROUND: As the coronavirus disease 2019 (COVID-19) pandemic unfolds, laboratory services have been identified as key to its containment. This article outlines the laboratory organisation and management and control interventions in Niger. INTERVENTION: The capitol city of Niger, Niamey, adopted a 'National COVID-19 Emergency Preparedness and Response Plan' to strengthen the preparedness of the country for the detection of severe acute respiratory syndrome coronavirus-2. Laboratory training and diagnostic capacity building were supported by existing active clinical and research laboratories for more rapid and practicable responses. The National Reference Laboratory for Respiratory Viruses located at the Centre de Recherche Médicale et Sanitaire was designated as the reference centre for COVID-19 testing. The national plan for COVID-19 testing is being gradually adopted in other regions of the country in response to the rapidly evolving COVID-19 emergency and to ensure a more rapid turn-around time. LESSONS LEARNT: After the decentralisation of COVID-19 testing to other regions of the country, turn-around times were reduced from 48-72 h to 12-24 h. Reducing turn-around times allowed Niger to reduce the length of patients' stays in hospitals and isolation facilities. Shortages in testing capacity must be anticipated and addressed. In an effort to reduce risk of shortages and increase availability of reagents and consumables, Niamey diversified real-time reverse transcriptase-polymerase chain reaction kits for severe acute respiratory syndrome coronavirus-2 detection. RECOMMENDATIONS: Continued investment in training programmes and laboratory strategy is needed in order to strengthen Niger's laboratory capacity against the outbreak.
© 2020. The Authors.

Entities:  

Keywords:  COVID-19; Niger; SARS-CoV-2; West Africa; coronavirus disease 2019; laboratory diagnosis; severe acute respiratory syndrome coronavirus-2

Year:  2020        PMID: 33392057      PMCID: PMC7756896          DOI: 10.4102/ajlm.v9i1.1308

Source DB:  PubMed          Journal:  Afr J Lab Med        ISSN: 2225-2002


  8 in total

1.  Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2.

Authors:  Catherine A Hogan; Malaya K Sahoo; ChunHong Huang; Natasha Garamani; Bryan Stevens; James Zehnder; Benjamin A Pinsky
Journal:  J Clin Virol       Date:  2020-04-24       Impact factor: 3.168

2.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.

Authors: 
Journal:  Nat Microbiol       Date:  2020-03-02       Impact factor: 17.745

3.  Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.

Authors:  Puck B van Kasteren; Bas van der Veer; Sharon van den Brink; Lisa Wijsman; Jørgen de Jonge; Annemarie van den Brandt; Richard Molenkamp; Chantal B E M Reusken; Adam Meijer
Journal:  J Clin Virol       Date:  2020-05-08       Impact factor: 3.168

4.  Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Authors:  Peter C Iwen; Karen L Stiles; Michael A Pentella
Journal:  Am J Clin Pathol       Date:  2020-04-15       Impact factor: 2.493

5.  Real-time RT-PCR in COVID-19 detection: issues affecting the results.

Authors:  Alireza Tahamtan; Abdollah Ardebili
Journal:  Expert Rev Mol Diagn       Date:  2020-04-22       Impact factor: 5.225

6.  Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2).

Authors:  Xueliang Wang; Hangping Yao; Xing Xu; Pengyin Zhang; Minmin Zhang; Junbin Shao; Yanqun Xiao; Hualiang Wang
Journal:  Clin Chem       Date:  2020-07-01       Impact factor: 8.327

7.  Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak.

Authors:  Luis Peñarrubia; Maria Ruiz; Roberto Porco; Sonia N Rao; Martí Juanola-Falgarona; Davide Manissero; Marta López-Fontanals; Josep Pareja
Journal:  Int J Infect Dis       Date:  2020-06-12       Impact factor: 3.623

8.  A novel strategy for community screening of SARS-CoV-2 (COVID-19): Sample pooling method.

Authors:  Khai Lone Lim; Nur Alia Johari; Siew Tung Wong; Loke Tim Khaw; Boon Keat Tan; Kok Keong Chan; Shew Fung Wong; Wan Ling Elaine Chan; Nurul Hanis Ramzi; Patricia Kim Chooi Lim; Sulaiman Lokman Hakim; Kenny Voon
Journal:  PLoS One       Date:  2020-08-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.